Navigation Links
EntreMed Announces Publication Of Preclinical Results For ENMD-2076 In Triple-negative Breast Cancer
Date:11/26/2012

selection, and may increase the probability of success. We are continuing to enroll patients in the ongoing Phase 2 trial and anticipate the initiation of a second site for this trial soon. We remain on track with our clinical development activities and expect our progress to accelerate in the coming months and year."

About EntreMed

EntreMed, Inc. is a clinical-stage pharmaceutical company employing a drug development strategy primarily in the United States and China to develop targeted therapeutics for the global market.  Its lead compound, ENMD-2076, a selective angiogenic kinase inhibitor, has completed several Phase 1 studies in solid tumors, multiple myeloma, and leukemia, and is currently completing a multi-center Phase 2 study in ovarian cancer. EntreMed, Inc. recently initiated a Phase 2 study of ENMD-2076 in triple-negative breast cancer.  Additional information about EntreMed is available on the Company's website at www.entremed.com and in various filings with the Securities and Exchange Commission (the SEC).

About ENMD-2076

ENMD-2076 is an orally-active, Aurora A/angiogenic kinase inhibitor with a unique kinase selectivity profile and multiple mechanisms of action. ENMD-2076 has been shown to inhibit a distinct profile of angiogenic tyrosine kinase targets in addition to the Aurora A kinase. Aurora kinases are key regulators of mitosis (cell division), and are often over-expressed in human cancers. ENMD-2076 also targets the VEGFR, Flt-3 and FGFR3 kinases which have been shown to play important roles in the pathology of several cancers. ENMD-2076 has shown promising activity in Phase 1 clinical trials in solid tumor cancers, leukemia, and multiple myeloma. ENMD-2076 is currently completing a Phase 2 trial for ovarian cancer.  EntreMed, Inc. recently initiated a Phase 2 study of ENMD-2076 in triple-negative breast cancer.

Forward Looking Statements   &#
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Dana-Farber Cancer Institutes Ursula A. Matulonis, MD Article on EntreMeds ENMD-2076 Published in the European Journal of Cancer
2. EntreMed Reports Second Quarter 2012 Financial Results
3. EntreMed Announces Initiation Of Phase 2 Trial In Triple-negative Breast Cancer
4. EntreMed Reports First Quarter 2012 Financial Results
5. Trovagene Announces Closing of Private Placement of $3.76 Million from the Sale of Restricted Common Stock and Warrants
6. ResMed Inc. Announces Exchange Rate For Upcoming Dividend Payment
7. AspenBio Pharma Announces Closing of Public Offering of 1,946,000 Shares of Common Stock
8. Vasomedical Announces Financial Results for the Third Quarter of 2012
9. Proteonomix, Inc. Announces Screening of Patients with End Stage Liver Disease in its Clinical Study of UMK-121
10. Ohr Pharmaceutical Announces Additions to Ophthalmic Scientific Advisory Board
11. NeuroDerm Announces Enrollment in a Phase 1 Study of ND0612, a Continuous Levodopa/Carbidopa Drug for the Treatment of Parkinsons Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... DIEGO , Nov. 25, 2014 Halozyme Therapeutics, ... the Piper Jaffray Healthcare Conference in New York ... EDT/10:00 a.m. PDT . Dr. Helen Torley , ... The presentation will be webcast through the "Investors" ... a recording will be made available for 90 days following ...
(Date:11/24/2014)... Nov. 24, 2014  Arena Pharmaceuticals, Inc. (NASDAQ: ... a corporate overview and update at the Piper Jaffray 26 ... at 8:30 a.m. Eastern Time (5:30 a.m. Pacific Time), at ... . A live audio webcast of the ... Arena,s website at www.arenapharm.com . A replay of the ...
(Date:11/24/2014)... -- Marta Rendon, MD, founder of the Rendon Center for Dermatology ... international key opinion leader in dermatology, was one of only ... to attend the international Aesthetic Experts Summit held ... at this gathering of over 600 physicians from 57 countries, ... experts from Asia and ...
Breaking Medicine Technology:Halozyme Therapeutics To Present At The Piper Jaffray Healthcare Conference 2Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 3Marta Rendon, MD Selected To Attend Prestigious, Global Aesthetic Experts Summit! 2Marta Rendon, MD Selected To Attend Prestigious, Global Aesthetic Experts Summit! 3
... Alcona Health Center is one of the first organizations ... payment after successfully meeting the requirements for Year One ... Alcona Health received a first-year incentive payment for each ... Medicare and Medicaid Services, resulting in one of the ...
... NxStage Medical, Inc. (Nasdaq: NXTM ), ... that Jeffrey H. Burbank, Chief Executive Officer, will present ... September 20th, at 3:00 p.m. ET.   A webcast ... http://www.nxstage.com/ir.cfm at the time of the presentation. ...
Cached Medicine Technology:SuccessEHS Client Among First in State of Michigan to Receive Medicaid Stimulus Funds 2SuccessEHS Client Among First in State of Michigan to Receive Medicaid Stimulus Funds 3SuccessEHS Client Among First in State of Michigan to Receive Medicaid Stimulus Funds 4
(Date:11/26/2014)... Arlington, VA (PRWEB) November 26, 2014 ... foster greater effectiveness in containing and stopping Ebola, ... long-term stability in healthcare systems in West Africa. ... Care Systems to Stop Ebola: Anthropologists Offer Insights,” ... held by the American Anthropological Association (AAA), Fri., ...
(Date:11/26/2014)... 2014 For those with a New Year’s ... MILLS BODYPUMP™ classes at the University of Colorado Anschutz ... been looking for. The 45- 60 minute classes have just ... Wellness Center fitness club memberships. , LES MILLS BODYPUMP™ exercise ... and are aimed at fast results , By focusing ...
(Date:11/26/2014)... of the most important and vital decisions a woman ... choosing the ideal wedding dress and bridesmaid dresses. BellasDress.com ... quality outfits. Today, BellasDress.com has unveiled its new range ... suitable bridesmaid gowns here at discount prices. , Formal ... and highlight all their most beautiful features while drawing ...
(Date:11/26/2014)... 2014 (HealthDay News) -- The number of emergency department visits ... 2010 to a record 136 million in 2011, according to ... findings also showed that fewer people were going to ERs ... as needing medical care within two hours of arriving at ... to the research. Sixty percent of patients arrived at ...
(Date:11/26/2014)... News) -- Parents need to take an active role ... warns. Parents must make sure sports-playing teens have ... Dodick, chair of the American Migraine Foundation and a ... Medicine in Scottsdale, Ariz. in an American Migraine Foundation, ... coach involved with teens sports needs to have appropriate ...
Breaking Medicine News(10 mins):Health News:Anthropologists Release Recommendations, Better Practices to Contain Ebola 2Health News:Anthropologists Release Recommendations, Better Practices to Contain Ebola 3Health News:LES MILLS BODYPUMP™ classes come to the University of Colorado Anschutz Health and Wellness Center 2Health News:Royal Blue Bridesmaid Dresses Now Are Available for Christmas at BellasDress.com 2Health News:ER Visits on the Rise, Study Reports 2Health News:Parents Need to Take Lead on Teen Concussion Prevention 2
... ... An Angel" Launches on iTunes August 25; Percentage of Proceeds to Inspire People to Sign ... , ... 25, 2009 -- All-4-One, the male vocal quartet that scored an international smash with the ...
... , ROCKVILLE, Md., Aug. 25 ... medicines for patients on behalf of both countries, the U.S. ... of the United Mexican States (FEUM) today agreed to collaborate ... a key component of public health, helping to ensure the ...
... , , CENTER CITY, Minn., ... people reclaim their lives from addiction, has appointed William C. ... (Logo: http://www.newscom.com/cgi-bin/prnh/20061128/CGTU038LOGO ) , (Photo: http://www.newscom.com/cgi-bin/prnh/20090825/DC66080 ... announce the appointment of William C. Moyers as Vice President ...
... common among visitors to Indian subcontinent, CDC reports , ... the most common cause of infection with an antimicrobial-resistant ... States, a new study finds. , About 300 cases ... each year, and the majority of these cases are ...
... factors other than gender may be to blame, researchers say ... likely to die than men in the 30 days after ... the trend, a new study finds. , Rather, "the difference ... as age and the presence of other illnesses, said study ...
... too little is known about these ,in situ, malignancies, experts ... of women with breast cancer in situ in the United States ... 2016 that number is expected to increase to more than 1 ... of newly diagnosed breast cancers. It is the early stage of ...
Cached Medicine News:Health News:R&B / Pop Vocal Quartet All-4-One Makes 7-Year Comeback 2Health News:R&B / Pop Vocal Quartet All-4-One Makes 7-Year Comeback 3Health News:Quality of Medicines Advanced by Agreement Between USP, Mexican Standards Body 2Health News:William C. Moyers Appointed Vice President of Foundation Relations for Hazelden 2Health News:International Travel Raises Risk of Typhoid 2Health News:Women More Prone to Die in Month After Heart Attack 2Health News:Women More Prone to Die in Month After Heart Attack 3Health News:More Women Surviving After Early Breast Cancer 2Health News:More Women Surviving After Early Breast Cancer 3
The Soft-Touch Timeter® Flowmeter is durable, long-lasting and easy to maintain. Timeter ® by Allied Flowmeters: Quality Plus Value....
The Soft-Touch Timeter® Flowmeter is durable, long-lasting and easy to maintain. Timeter ® by Allied Flowmeters: Quality Plus Value....
The Soft-Touch Timeter® Flowmeter is durable, long-lasting and easy to maintain. Timeter ® by Allied Flowmeters: Quality Plus Value....
... offers a complete line of flowmeters, ... CO 2 . They are all ... to best suit your application. With ... to the gas in use, the ...
Medicine Products: